211 related articles for article (PubMed ID: 24088271)
1. Early treatment with IgM-enriched intravenous immunoglobulin does not mitigate critical illness polyneuropathy and/or myopathy in patients with multiple organ failure and SIRS/sepsis: a prospective, randomized, placebo-controlled, double-blinded trial.
Brunner R; Rinner W; Haberler C; Kitzberger R; Sycha T; Herkner H; Warszawska J; Madl C; Holzinger U
Crit Care; 2013 Oct; 17(5):R213. PubMed ID: 24088271
[TBL] [Abstract][Full Text] [Related]
2. Risk factors for the development of polyneuropathy and myopathy in critically ill patients.
de Letter MA; Schmitz PI; Visser LH; Verheul FA; Schellens RL; Op de Coul DA; van der Meché FG
Crit Care Med; 2001 Dec; 29(12):2281-6. PubMed ID: 11801825
[TBL] [Abstract][Full Text] [Related]
3. Critical illness polyneuropathy and myopathy: clinical features, risk factors and prognosis.
Visser LH
Eur J Neurol; 2006 Nov; 13(11):1203-12. PubMed ID: 17038033
[TBL] [Abstract][Full Text] [Related]
4. Effects of early treatment with immunoglobulin on critical illness polyneuropathy following multiple organ failure and gram-negative sepsis.
Mohr M; Englisch L; Roth A; Burchardi H; Zielmann S
Intensive Care Med; 1997 Nov; 23(11):1144-9. PubMed ID: 9434920
[TBL] [Abstract][Full Text] [Related]
5. ["Critical-illness" polyneuropathy and -myopathy].
Leijten FS; de Letter MA; Op de Coul AA
Ned Tijdschr Geneeskd; 2000 Jul; 144(30):1428-32. PubMed ID: 10932694
[TBL] [Abstract][Full Text] [Related]
6. Clinical experience with polyclonal IgM-enriched immunoglobulins in a group of patients affected by sepsis after cardiac surgery.
Buda S; Riefolo A; Biscione R; Goretti E; Cattabriga I; Grillone G; Bacchi-Reggiani L; Pacini D
J Cardiothorac Vasc Anesth; 2005 Aug; 19(4):440-5. PubMed ID: 16085247
[TBL] [Abstract][Full Text] [Related]
7. Intravenous immunoglobulin treatment in chronic inflammatory demyelinating polyneuropathy. A double-blind, placebo-controlled, cross-over study.
Hahn AF; Bolton CF; Zochodne D; Feasby TE
Brain; 1996 Aug; 119 ( Pt 4)():1067-77. PubMed ID: 8813271
[TBL] [Abstract][Full Text] [Related]
8. [Efficacy of intravenous immunoglobulin in the adjuvant treatment of patients with severe sepsis: a Meta analysis].
Qing Z; Luo Y; Yan S; Zhu H; Huang P; Zhou Z; Shen H; Xie B; He W; Liu X; Li Y; Xu Y
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2016 May; 28(5):407-12. PubMed ID: 29920032
[TBL] [Abstract][Full Text] [Related]
9. Effects of high-dose of intravenous immunoglobulin and antibiotics on survival for severe sepsis undergoing surgery.
Rodríguez A; Rello J; Neira J; Maskin B; Ceraso D; Vasta L; Palizas F
Shock; 2005 Apr; 23(4):298-304. PubMed ID: 15803051
[TBL] [Abstract][Full Text] [Related]
10. A controlled trial of intravenous immunoglobulin in multifocal motor neuropathy.
Hahn AF; Beydoun SR; Lawson V; ; Oh M; Empson VG; Leibl H; Ngo LY; Gelmont D; Koski CL
J Peripher Nerv Syst; 2013 Dec; 18(4):321-30. PubMed ID: 24725024
[TBL] [Abstract][Full Text] [Related]
11. Electrical muscle stimulation prevents critical illness polyneuromyopathy: a randomized parallel intervention trial.
Routsi C; Gerovasili V; Vasileiadis I; Karatzanos E; Pitsolis T; Tripodaki E; Markaki V; Zervakis D; Nanas S
Crit Care; 2010; 14(2):R74. PubMed ID: 20426834
[TBL] [Abstract][Full Text] [Related]
12. Effects of IgM-enriched immunoglobulin and fluid replacement on nerve conduction velocity in experimental sepsis.
Cankayali I; Doğan YH; Solak I; Eriş O; Demirgören S; Moral AR
Ulus Travma Acil Cerrahi Derg; 2010 Jan; 16(1):9-14. PubMed ID: 20209389
[TBL] [Abstract][Full Text] [Related]
13. Is plasma calcium concentration implicated in the development of critical illness polyneuropathy and myopathy?
Anastasopoulos D; Kefaliakos A; Michalopoulos A
Crit Care; 2011; 15(5):R247. PubMed ID: 22018206
[TBL] [Abstract][Full Text] [Related]
14. Prospective, double-blind, randomized, placebo-controlled phase III study evaluating efficacy and safety of octagam 10% in patients with dermatomyositis ("ProDERM Study").
Aggarwal R; Charles-Schoeman C; Schessl J; Dimachkie MM; Beckmann I; Levine T
Medicine (Baltimore); 2021 Jan; 100(1):e23677. PubMed ID: 33429735
[TBL] [Abstract][Full Text] [Related]
15. Comparison of two types of intravenous immunoglobulins in the treatment of neonatal sepsis.
Haque KN; Remo C; Bahakim H
Clin Exp Immunol; 1995 Aug; 101(2):328-33. PubMed ID: 7648717
[TBL] [Abstract][Full Text] [Related]
16. Role of pentoxifylline and/or IgM-enriched intravenous immunoglobulin in the management of neonatal sepsis.
Akdag A; Dilmen U; Haque K; Dilli D; Erdeve O; Goekmen T
Am J Perinatol; 2014 Nov; 31(10):905-12. PubMed ID: 24515621
[TBL] [Abstract][Full Text] [Related]
17. [Critical illness polyneuropathy and critical illness myopathy].
Grimm A; Günther A; Witte OW; Axer H
Med Klin Intensivmed Notfmed; 2012 Nov; 107(8):649-58; quiz 659. PubMed ID: 23104463
[TBL] [Abstract][Full Text] [Related]
18. Reduced incidence of postoperative infection after intravenous administration of an immunoglobulin A- and immunoglobulin M-enriched preparation in anergic patients undergoing cardiac surgery.
Kress HG; Scheidewig C; Schmidt H; Silber R
Crit Care Med; 1999 Jul; 27(7):1281-7. PubMed ID: 10446821
[TBL] [Abstract][Full Text] [Related]
19. Intravenous immunoglobulin therapy in multifocal motor neuropathy: a double-blind, placebo-controlled study.
Léger JM; Chassande B; Musset L; Meininger V; Bouche P; Baumann N
Brain; 2001 Jan; 124(Pt 1):145-53. PubMed ID: 11133794
[TBL] [Abstract][Full Text] [Related]
20. Randomised placebo-controlled trial of monthly intravenous immunoglobulin therapy in relapsing-remitting multiple sclerosis. Austrian Immunoglobulin in Multiple Sclerosis Study Group.
Fazekas F; Deisenhammer F; Strasser-Fuchs S; Nahler G; Mamoli B
Lancet; 1997 Mar; 349(9052):589-93. PubMed ID: 9057729
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
